Literature DB >> 4133182

Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen.

L Lorand, A J Gray, K Brown, R B Credo, C G Curtis, R A Domanik, P Stenberg.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4133182     DOI： 10.1016/s0006-291x(74)80275-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  14 in total

1.  Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.

Authors:  J D Beckman; L A Holle; A S Wolberg
Journal:  J Thromb Haemost       Date:  2017-11-20       Impact factor: 5.824

2.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 3.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

4.  Genetic polymorphism of the A subunit of human coagulation factor XIII.

Authors:  P G Board
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

5.  Human coagulation factor XIII A (F XIII A) phenotyping by immunofixation agarose gel electrophoresis (IAGE).

Authors:  P Kreckel; P Kühnl; W Spielmann
Journal:  Blut       Date:  1982-05

6.  Genetic polymorphism of the B subunit of human coagulation factor XIII.

Authors:  P G Board
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

8.  Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines.

Authors:  P Stenberg; C G Curtis; D Wing; Y S Tong; R B Credo; A Gray; L Lorand
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

9.  Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.

Authors:  S Lopaciuk; K Bykowska; J M McDonagh; R P McDonagh; W J Yount; C R Fuller; L Cooperstein; A Gray; L Lorand
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Fibrin cross-linking in congenital factor XIII deficiency.

Authors:  F Rodeghiero; T Barbui
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.